Stratec SE (SBS F) stock market data APIs
€22.1838
0.01(0%)
as of January 20, 2026
Try our APIs with
free plan!
Stratec SE Financial Data Overview
Price chart is built with
Anychart
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Prev. Close
22.1838
Open
22.1889
High
22.2108
Low
22.1463
52 wk Range
19.7-36.0708
Market Cap
269 M
P/E Ratio
17.4016
Shares Outstanding
12 156 K
Revenue
260 M
EPS
0.22
Dividends (Yield)
0.026
Beta
0.704
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Stratec SE data using free add-ons & libraries
Get Stratec SE Fundamental Data
Stratec SE Fundamental data includes:
- Net Revenue: 260 M
- EBITDA: 39 695 K
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-10-25
- EPS/Forecast: 0.38
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Stratec SE News
New
Stratec SE (ETR:SBS) Shares Could Be 35% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Stratec fair value estimate is €68.78 Stratec is estimated to be 35% undervalued based on current share price of €44.90 Our fair value est...
Declining Stock and Decent Financials: Is The Market Wrong About Stratec SE (ETR:SBS)?
With its stock down 9.6% over the past three months, it is easy to disregard Stratec (ETR:SBS). However, the company's fundamentals look pretty decent, and long-term financials are usually aligned wit...
Stratec's (ETR:SBS) Returns Have Hit A Wall
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? One common approach is to try and find a company with returns on capital employed ...
Stratec (ETR:SBS) investors are sitting on a loss of 65% if they invested three years ago
Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have been particularly tough on longer term Stratec SE (ETR:SBS) shareholders. Sadly for t...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
